Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes

被引:68
作者
Egan, AM [1 ]
Gordon, DL [1 ]
机构
[1] FLINDERS UNIV S AUSTRALIA,MED CTR,DEPT MICROBIOL & INFECT DIS,BEDFORD PK,SA 5042,AUSTRALIA
关键词
D O I
10.1128/IAI.64.12.4952-4959.1996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mechanism by which Burkholderia pseudomallei is resistant to lysis by human serum is unknown but may include interference with complement activation, effective opsonization, or complement-mediated lysis. We investigated the interaction of B. pseudomallei with complement in the presence and absence of specific antibody to determine potential mechanisms of serum resistance. We demonstrated rapid activation and consumption of complement by B. pseudomallei which, in the absence of specific antibody, occurred predominantly via the alternative pathway. Complement activation was associated with deposition of the opsonically active C3b and iC3b fragments on the bacterial surface. C5b-9, detected on the bacterial surface after opsonic periods of 1 to 60 min, was susceptible to elution by 1 M NaCl, indicating that resistance to complement-mediated lysis may result from deposition of the membrane attack complex in a nonmicrobicidal location. To define the role of opsonins, we investigated the ability of polymorphonuclear leukocytes (PMNL) to phagocytose B. pseudomallei. Phagocytosis of bacteria by PMNL, and the observed oxidative response, was significantly increased by opsonization of organisms with complement and/or specific antibody. Despite opsonophagocytosis by PMNL and the production of an oxidative response, no significant bacterial killing was observed.
引用
收藏
页码:4952 / 4959
页数:8
相关论文
共 41 条
[1]   ENZYME-LINKED IMMUNOSORBENT-ASSAY FOR THE DIAGNOSIS OF CLINICAL AND SUBCLINICAL MELIOIDOSIS [J].
ASHDOWN, LR ;
JOHNSON, RW ;
KOEHLER, JM ;
COONEY, CA .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (02) :253-260
[2]   IDENTIFICATION OF PSEUDOMONAS-PSEUDOMALLEI IN THE CLINICAL LABORATORY [J].
ASHDOWN, LR .
JOURNAL OF CLINICAL PATHOLOGY, 1979, 32 (05) :500-504
[3]  
ASHDOWN LR, 1984, AM J TROP MED HYG, V33, P474, DOI 10.4269/ajtmh.1984.33.474
[4]   IMPROVED SCREENING TECHNIQUE FOR ISOLATION OF PSEUDOMONAS-PSEUDOMALLEI FROM CLINICAL SPECIMENS [J].
ASHDOWN, LR .
PATHOLOGY, 1979, 11 (02) :293-297
[5]  
CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181
[6]   MELIOIDOSIS - THE TIP OF THE ICEBERG [J].
DANCE, DAB .
CLINICAL MICROBIOLOGY REVIEWS, 1991, 4 (01) :52-60
[7]   MELIOIDOSIS - PATHOGENESIS AND IMMUNITY IN MICE AND HAMSTERS .1. STUDIES WITH VIRULENT STRAINS OF MALLEOMYCES PSEUDOMALLEI [J].
DANNENBERG, AM ;
SCOTT, EM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1958, 107 (01) :153-+
[8]   RELATIONSHIPS AMONG PSEUDOMONAS-PSEUDOMALLEI ISOLATES FROM PATIENTS WITH RECURRENT MELIOIDOSIS [J].
DESMARCHELIER, PM ;
DANCE, DAB ;
CHAOWAGUL, W ;
SUPUTTAMONGKOL, Y ;
WHITE, NJ ;
PITT, TL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (06) :1592-1596
[9]   ROLES OF COMPLEMENT AND COMPLEMENT RECEPTOR TYPE-3 IN PHAGOCYTOSIS OF LISTERIA-MONOCYTOGENES BY INFLAMMATORY MOUSE PERITONEAL-MACROPHAGES [J].
DREVETS, DA ;
CAMPBELL, PA .
INFECTION AND IMMUNITY, 1991, 59 (08) :2645-2652
[10]   IDENTIFICATION OF THE MEMBRANE GLYCOPROTEIN THAT IS THE C3B RECEPTOR OF THE HUMAN-ERYTHROCYTE, POLYMORPHONUCLEAR LEUKOCYTE, LYMPHOCYTE-B, AND MONOCYTE [J].
FEARON, DT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (01) :20-30